{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=sca3", "query": { "condition": "sca3" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=sca3&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T09:43:41.492Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00992771", "title": "Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Spinocerebellar Ataxia Type 3" ], "interventions": [ { "name": "varenicline", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2009-10", "completion_date": "2011-04", "has_results": false, "last_update_posted_date": "2012-06-18", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 3, "location_summary": "Los Angeles, California • Gainesville, Florida • Tampa, Florida", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00992771" }, { "nct_id": "NCT03885167", "title": "Identification of Biomarkers in Spinocerebellar Ataxia 3", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinocerebellar Ataxia Type 3" ], "interventions": [ { "name": "Specimen Collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2019-02-21", "completion_date": "2023-01-04", "has_results": false, "last_update_posted_date": "2023-11-22", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03885167" }, { "nct_id": "NCT03487367", "title": "Clinical Trial Readiness for SCA1 and SCA3", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia 3" ], "interventions": [], "intervention_types": [], "sponsor": "The Methodist Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 200, "start_date": "2018-08-16", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2022-01-19", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03487367" }, { "nct_id": "NCT05490563", "title": "STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Spinocerebellar Ataxia Type 3" ], "interventions": [ { "name": "SLS-005", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Seelos Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 23, "start_date": "2022-06-03", "completion_date": "2023-11-24", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 7, "location_summary": "Los Angeles, California • Aurora, Colorado • Tampa, Florida + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05490563" }, { "nct_id": "NCT01060371", "title": "Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 6" ], "interventions": [ { "name": "All Participants", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 800, "start_date": "2010-04", "completion_date": "2024-05-19", "has_results": false, "last_update_posted_date": "2023-06-01", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 12, "location_summary": "Los Angeles, California • San Francisco, California • Gainesville, Florida + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01060371" }, { "nct_id": "NCT04301284", "title": "Study of CAD-1883 for Spinocerebellar Ataxia", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Spinocerebellar Ataxias", "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 6", "Spinocerebellar Ataxia Type 7", "Spinocerebellar Ataxia Type 8", "Spinocerebellar Ataxia Type 10", "Spinocerebellar Ataxia Type 17", "ARCA1 - Autosomal Recessive Cerebellar Ataxia Type 1" ], "interventions": [ { "name": "CAD-1883", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cadent Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2021-06", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2021-04-08", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 6, "location_summary": "Long Beach, California • Los Angeles, California • Aurora, Colorado + 3 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04301284" }, { "nct_id": "NCT03408080", "title": "Open Pilot Trial of BHV-4157", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spinocerebellar Ataxias", "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia 3", "Spinocerebellar Ataxia Type 6", "MSA-C" ], "interventions": [ { "name": "BHV-4157", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 24, "start_date": "2017-12-15", "completion_date": "2024-12-15", "has_results": false, "last_update_posted_date": "2024-05-09", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03408080" }, { "nct_id": "NCT03701399", "title": "Troriluzole in Adult Participants With Spinocerebellar Ataxia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spinocerebellar Ataxias", "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 6", "Spinocerebellar Ataxia Type 7", "Spinocerebellar Ataxia Type 8", "Spinocerebellar Ataxia Type 10" ], "interventions": [ { "name": "troriluzole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biohaven Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 299, "start_date": "2019-03-08", "completion_date": "2026-06", "has_results": true, "last_update_posted_date": "2025-11-04", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Long Beach, California • Los Angeles, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03701399" }, { "nct_id": "NCT05160558", "title": "A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Spinocerebellar Ataxia Type 3" ], "interventions": [ { "name": "BIIB132", "type": "DRUG" }, { "name": "BIIB132-Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 8, "start_date": "2022-02-02", "completion_date": "2023-07-25", "has_results": false, "last_update_posted_date": "2023-08-04", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 10, "location_summary": "Los Angeles, California • San Francisco, California • Gainesville, Florida + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05160558" }, { "nct_id": "NCT00654251", "title": "Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinocerebellar Ataxia" ], "interventions": [], "intervention_types": [], "sponsor": "University of Mississippi Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2008-02", "completion_date": "2009-02", "has_results": false, "last_update_posted_date": "2009-04-29", "last_synced_at": "2026-05-22T09:43:41.492Z", "location_count": 2, "location_summary": "Jackson, Mississippi • Galveston, Texas", "locations": [ { "city": "Jackson", "state": "Mississippi" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00654251" } ] }